ICAAC 2009 (9/14/09)
 
Ampicillin Enhances the Activity of Daptomycin by Alteration of Surface Charge in Vancomycin-Resistant Enterococcus faecium
Ampicillin Enhances the Activity of Daptomycin by Alteration of Surface Charge in Vancomycin-Resistant Enterococcus faecium
George Sakoulas, MD
 
Permeability of the Blood Brain Barrier (BBB) to Amphotericin B (AMB) is Focally Increased in Experimental Hematogenous Candida Meningoencephalitis (HCME)
Permeability of the Blood Brain Barrier (BBB) to Amphotericin B (AMB) is Focally Increased in Experimental Hematogenous Candida Meningoencephalitis (HCME)
Vasilios Pyrgos, M.D.
 
Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Treated with Vancomycin
Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Treated with Vancomycin
Ravina Kullar, PharmD
 
Evaluating the Efficacy of Anti-Infective Endotracheal Tubes (ETT) inPreventing Biofilm Colonization (BC) of Multidrug-Resistant Bacteria (MDRB)Associated with Ventilator-Associated Pneumonia (VAP)
Evaluating the Efficacy of Anti-Infective Endotracheal Tubes (ETT) in Preventing Biofilm Colonization (BC) of Multidrug-Resistant Bacteria (MDRB) Associated with Ventilator-Associated Pneumonia (VAP)
I.I. Raad, R. Hachem, T. Dvorak, R. Reitzel
 
Interim Analysis of a Phase 2 Trial of a Therapeutic DNA Vaccine (VCL-CB01) for Control of Cytomegalovirus in Stem Cell Transplant Recipients
Interim Analysis of a Phase 2 Trial of a Therapeutic DNA Vaccine (VCL-CB01) for Control of Cytomegalovirus in Stem Cell Transplant Recipients
Wilck M, Chu A, Wloch M, Guterwill D, Smith L, Rolland A
 
24 Week Safety and Efficacy from IMPAACT 1066: A Phase I/II, Multicenter, Open-Label, Noncomparative Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth
24 Week Safety and Efficacy from IMPAACT 1066: A Phase I/II, Multicenter, Open-Label, Noncomparative Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth
Lisa Frenkel
 
Potential vaccine targets in Staphylococcus epidermis
Potential vaccine targets in Staphylococcus epidermis
Mohammad Shahrooei
 
Breakthrough Invasive Candidiasis on Micafungin
Breakthrough Invasive Candidiasis on Micafungin
David S. Perlin, PhD
 
The pharmacodynamics of Telavancin against Vancomycin susceptible MRSA and Vancomycin intermediate S.aureus strains
The pharmacodynamics of Telavancin against Vancomycin susceptible MRSA and Vancomycin intermediate S.aureus strains
AR Noel, KE Bowker, SG Tomaselli, HC Elliott, AP MacGowan